Orange Stock Falls 5% and Becomes CAC 40 Worst Performer
Orange records the steepest decline on the CAC 40 this Friday, within a Paris index already trending downward. Morgan Stanley's downgrade directly weighs on the share price, while the stock slips below its three moving averages and approaches its support threshold.
Morgan Stanley Lowers Rating and Amplifies Pressure on Share Price
This Friday, September 18, Morgan Stanley downgraded its opinion on Orange from "market perform" to "underperform", while lowering its price target from €16.50 to €15.00. At this level, the American bank's target implies a downside potential of nearly 1% compared to the current price, signaling an unfavorable short-term outlook. This move contrasts with the analyst consensus from JP Morgan, which maintained its "overweight" rating on Wednesday while raising its target from €21.80 to €22.50, representing an upside potential of over 48% compared to the current price.
This dual signal from contradictory analysts reflects a highly divergent reading of the group's prospects, as the stock falls 5.04% to €15.16 in trading, the worst performer on the CAC 40 which declines 0.69%. When Orange published its H1 2026 results on July 28, it had nonetheless raised its annual targets, relying on exclusive control of MasOrange in Spain and double-digit growth in Africa and the Middle East. But net debt rising to €35.7 billion following MasOrange integration, combined with persistent difficulties at Orange Business, remains a friction point that Morgan Stanley now appears to view as heavier than anticipated.
Share Price Approaches Its €15.10 Support Below All Moving Averages
On a technical level, today's decline brings the stock to its support at €15.10, a difference of less than 0.4% compared to the current price. The stock is trading below its three moving averages: the 20-day MA at €15.61 (difference of -2.91%), the 50-day MA at €16.06 (-5.64%) and the 200-day MA at €16.48 (-8.04%). This configuration confirms sustained downward pressure across all timeframes, with a resistance level at €16.46 that coincides with the 200-day MA and represents a difference of over 8% above the current price. The RSI at 56 remains in neutral territory despite today's decline, reflecting genuine tension without an oversold signal.
Over one month, the stock has fallen 6.42%, and over three months 10.51%, amid a backdrop of rising global interest rates: the Fed raised its rates on Wednesday for the first time since 2023, and the Bank of Japan increased its rate to 1.25% today. Orange, whose balance sheet carries significant debt, is historically sensitive to changes in financing conditions. The €15.10 support level now represents the key level to watch for the remainder of the session.
